|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash flows provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred loan costs | |||||
| Provision for uncollectibles | |||||
| Net (gain) loss on sale of long-lived assets | |||||
| Net gain on deconsolidations | |||||
| Share-based compensation | |||||
| Excess tax benefit from share-based compensation | |||||
| Deferred income taxes | |||||
| Equity in earnings of unconsolidated affiliates | |||||
| Debt extinguishment costs | |||||
| Net change in fair value of contingent consideration | |||||
| Increases (decreases) in cash and cash equivalents, net of acquisitions and dispositions: | |||||
| Accounts receivable | |||||
| Supplies inventory | |||||
| Prepaid and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Other, net | |||||
| Net cash flows provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions and related expenses | |||||
| Acquisition of property and equipment | |||||
| Proceeds from sale of interests in surgery centers | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Other | |||||
| Net cash flows used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from long-term borrowings and revolving credit facility | |||||
| Repayment on long-term borrowings and revolving credit facility | |||||
| Distributions to noncontrolling interests | |||||
| Proceeds from preferred stock offering | |||||
| Cash dividends for preferred shares | |||||
| Proceeds from common stock offering | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Repurchase of common stock | |||||
| Capital contributions and ownership transactions by noncontrolling interests | |||||
| Excess tax benefit from share-based compensation | |||||
| Payments of equity issuance costs | |||||
| Financing costs incurred | |||||
| Other | |||||
| Net cash flows provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow information: | |||||
| Interest payments | |||||
| Income tax payments, net of refunds | |||||
Loading...